10-Q: Rayonier Advanced Materials Reports Q3 Loss, Eyes Future Growth

Rayonier Advanced Materials reported a net loss for Q3 2025, but showed operational improvements compared to the prior year, while outlining an optimistic long-term growth strategy.

Summary

• Net sales for the three months ended September 27, 2025, decreased by $48 million (12%) to $353 million compared to the same prior year quarter.
• Net loss attributable to RYAM for Q3 2025 improved significantly to $4.5 million, compared to a $32.6 million loss in Q3 2024.
• Operating income for Q3 2025 was $9.7 million, a substantial improvement from an operating loss of $16.8 million in Q3 2024.
• For the nine months ended September 27, 2025, net sales decreased by $159 million (13%) to $1.05 billion.
• The nine-month net loss attributable to RYAM was $399.6 million, significantly worse than the $22.8 million loss in the prior year, primarily due to a $337 million non-cash write-off of Canadian Deferred Tax Assets (DTAs).
• Cash used in operating activities for the nine months was $8.3 million, a decrease of $157 million compared to $149 million provided in the prior year period.
• Adjusted Free Cash Flow for the nine months was negative $83 million, down from positive $99 million in the prior year period.
• The company projects full-year 2025 Adjusted EBITDA to approximate $135 million to $140 million, including a $12 million non-cash environmental charge.
• Q4 Adjusted Free Cash Flow is expected to be $25 million to $30 million, reflecting improved working capital conversion.
• The company expects to more than double EBITDA over the next two years, targeting over $300 million in run-rate EBITDA by the end of 2027.

Sentiment

Score: 5

Explanation: The sentiment is mixed. While Q3 operating results showed improvement and the company has an optimistic long-term outlook with strategic biomaterials investments and cost-saving initiatives, the nine-month financial performance was significantly negative due to a large DTA write-off and declining cash flow. Market headwinds in Paperboard and High-Yield Pulp, coupled with increasing environmental liabilities and project delays, temper the positive future projections.

Positives

• Operating income for Q3 2025 improved by $26 million (153%) compared to Q3 2024, driven by the absence of prior year asset impairment and indefinite suspension costs, lower fixed costs, favorable foreign exchange rates, and an $8 million energy cost benefit.
• Net loss attributable to RYAM for Q3 2025 significantly narrowed to $4.5 million from $32.6 million in Q3 2024.
• Cellulose Specialties segment operating income increased by $3 million (7%) in Q3 2025, benefiting from higher average sales prices and lower fixed costs.
• The Biomaterials strategy is advancing with the bioethanol facility in France operational since Q1 2024 and the lignosulfonate powder plant re-started in Q1 2025.
• Received Generally Recognized As Safe (GRAS) status for the prebiotics product from the U.S. Food and Drug Administration in July 2025, with a Memorandum of Understanding signed with a feed additive manufacturer.
• The AGE project (green electricity in Georgia) has completed construction planning, obtained an air permit, and executed an Engineering, Procurement and Construction agreement.
• Expanded the Kallima portfolio in October 2025 with an enhanced freezer application for folding carton board, designed for temperatures as low as -18C (0F) without coatings or plastic extrusion.
• RYAM and USW jointly filed petitions against Brazilian and Norwegian HPDP producers, with the USITC issuing an affirmative injury determination in September 2025, advancing the case to the USDOC for preliminary determinations in H1 2026.
• Management projects significant future growth, aiming to more than double EBITDA over the next two years and achieve over $300 million in run-rate EBITDA by the end of 2027.

Negatives

• Net sales decreased across all segments for both the three and nine months ended September 27, 2025, primarily due to lower sales volumes, tariffs, competitive activity, and operational challenges.
• The nine-month net loss attributable to RYAM was $399.6 million, significantly worse than the prior year, largely due to a $337 million non-cash write-off of Canadian Deferred Tax Assets (DTAs).
• Cash used in operating activities for the nine months ended September 27, 2025, was $8.3 million, a substantial decline from $149 million provided in the prior year period.
• Adjusted Free Cash Flow for the nine months was negative $83 million, compared to positive $99 million in the prior year.
• Operating income for the nine months ended September 27, 2025, declined by $35 million (125%) compared to the prior year, driven by lower sales, higher costs from operational challenges and labor strikes at the Tartas cellulose plant, and $12 million in non-cash environmental reserve charges.
• Paperboard and High-Yield Pulp segments experienced declines in net sales and operating income/loss due to lower demand, increased competitive activity, and oversupply in the Chinese market for High-Yield Pulp.
• Paperboard and High-Yield Pulp production lines are being idled for three weeks in Q4 2025 to manage inventory and preserve cash flow due to ongoing market weakness.
• The debt to capital ratio increased significantly to 70% as of September 27, 2025, from 51% at December 31, 2024.
• The City of Fernandina Beach denied the site plan application for a potential bioethanol facility, requiring the company to pursue administrative and legal avenues.

Risks

• Potential for additional environmental liabilities up to approximately $78 million due to changes in laws, regulations, governmental agency policies, remediation technologies, and costs.
• Inherent uncertainty in the fair value measurement of Level 3 securities, such as the SWEN put option, due to the use of unobservable inputs.
• Exposure to market risks including changes in interest rates, currency fluctuations, and commodity prices.
• Cyclical nature of prices, sales volumes, and margins for Cellulose Commodities and High-Yield Pulp products, driven by economic shifts, capacity fluctuations, and foreign currency exchange rates.
• Impact of Chinese retaliatory tariffs disrupting global fluff market dynamics and creating a mismatch between supply and demand.
• Continued economic uncertainty and weaker customer demand affecting Paperboard sales volumes.
• Increased competitive activity from European Union imports and new U.S. competitor capacity impacting Paperboard pricing.
• Oversupply in the Chinese market and increased competitive activity from new Indonesian capacity affecting High-Yield Pulp sales prices and volumes.
• Operational challenges and labor strikes, such as those at the Tartas cellulose plant, can negatively impact production efficiency and costs.
• The potential sale of Paperboard and High-Yield Pulp businesses remains uncertain due to current market dynamics, evolving trade conditions, and ongoing discussions related to the renewal of the US-Mexico-Canada Agreement.

Future Outlook

The company anticipates a strong finish to 2025, with full-year Adjusted EBITDA projected between $135 million and $140 million, supported by stable Cellulose Specialties operations, improved order trends, and continued cost discipline. Q4 Adjusted Free Cash Flow is expected to be $25 million to $30 million due to improved working capital conversion. Looking ahead, the company expects to more than double EBITDA over the next two years, driven by multi-year Cellulose Specialties price actions, efficiency gains, and structural cost reductions targeting $30 million in annual savings by 2026, with potential for an additional $20 million in 2027. Biomaterials projects are expected to add $31 million of run-rate proportional EBITDA exiting 2027, reinforcing a path to over $300 million in run-rate EBITDA by the end of 2027, with further upside from the AGE project coming online in late 2028. The potential sale of Paperboard and High-Yield Pulp businesses remains under evaluation given market dynamics and trade conditions.

Management Comments

• We continue to expect a strong finish to 2025, with annual Adjusted EBITDA projected to approximate $135 million to $140 million, inclusive of the $12 million non-cash environmental charge taken in the first quarter, supported by stable Cellulose Specialties operations, improved order trends and continued cost discipline.
• Adjusted Free Cash Flow is expected to approximate $25 million to $30 million in the fourth quarter, reflecting improved working capital conversion and stronger financial performance as orders continue to normalize.
• Looking ahead, we expect to more than double EBITDA over the next two years. This growth will be driven by multi-year Cellulose Specialties price actions, continued efficiency gains and structural cost reductions targeting approximately $30 million in annual savings by 2026.
• Beyond 2026, we are also evaluating incremental cost saving opportunities, with initiatives under review that could deliver up to $20 million of additional annual savings in 2027.
• Biomaterials projects are expected to add approximately $31 million of run-rate proportional EBITDA exiting 2027. Collectively, these actions reinforce RYAMs long-term strategy and our path to achieve over $300 million in run-rate EBITDA by the end of 2027, with further upside as the AGE project comes online in late 2028.
• We remain committed to disciplined capital allocation and cash management.
• The previously announced process to explore a potential sale of our Paperboard and High-Yield Pulp businesses remains in flux given current market dynamics, evolving trade conditions and ongoing discussions related to the renewal of the US-Mexico-Canada Agreement in July 2026. We continue to engage opportunistically with interested parties as inbound inquiries arise, while evaluating options that best support long-term value creation and balance sheet deleveraging.

Industry Context

The company operates in a challenging global market, facing Chinese retaliatory tariffs disrupting fluff market dynamics and creating supply-demand mismatches. The paperboard sector is experiencing soft sales volumes due to economic uncertainty, weaker customer demand, increased competitive activity from European Union imports, and new U.S. competitor capacity. The high-yield pulp market is also impacted by continued oversupply in China and increased competitive activity from new Indonesian capacity. Despite these headwinds, the company is strategically investing in biomaterials and green energy, aligning with broader industry trends towards sustainability and renewable products, such as bioethanol, prebiotics, and sustainable aviation fuel (SAF). The expansion into enhanced freezer application for folding carton board capitalizes on the growing worldwide frozen food market driven by consumer demand for convenience and extended shelf life.

Comparison to Industry Standards

• The North American paperboard shipment to capacity ratio is below analysts' projections for 2025, indicating a weaker market than anticipated by industry experts.
• The company's prebiotics product showed over two times greater efficacy versus an existing prebiotics additive in live animal tests, suggesting a competitive advantage in the feed additive market.

Corporate Governance

Legal Proceedings

• RYAM and USW jointly filed petitions with the USITC and the USDOC alleging that Brazilian and Norwegian producers of High Purity Dissolving Pulp (HPDP) are selling into the U.S. market at unfairly low prices or with government subsidies, causing material injury to the U.S. HPDP industry and its workers. The USITC issued an affirmative injury determination in September 2025, advancing the case to the USDOC.
• The company is pursuing available administrative and legal avenues after the City of Fernandina Beach denied the site plan application for a potential bioethanol facility.

Related Party Transactions

• The company is a partner in Altamaha Green Energy LLC (AGE) under a preliminary agreement with Beasley Green Power, LLC. AGE expenses have been shared evenly by RYAM and Beasley.
• In November 2024, the company and one of its subsidiaries entered into a shareholder agreement with SWEN, pursuant to which SWEN will fund up to 30 million EUR in exchange for up to a 20 percent preferred equity interest in BioNova, a RYAM subsidiary. 15 million EUR was funded at closing.
• LTF (LignoTech Florida LLC) is a venture in which the company owns 45 percent, and its partner, Borregaard ASA, owns 55 percent. The company is a guarantor of LTF's financing agreements for its proportional share of $25 million.

Stakeholder Impact

• Shareholders: Experienced a significant net loss for the nine months due to a non-cash DTA write-off, but Q3 operating performance improved. Future outlook projects significant EBITDA growth and cost savings, potentially increasing shareholder value long-term. Dividend remains suspended.
• Employees: Collective bargaining agreements at the Jesup plant were successfully renewed in Q3 2025. Indefinite suspension of Temiscaming cellulose operations resulted in severance costs in the prior year.
• Customers: New Kallima freezer application offers enhanced product integrity, cost efficiency, and sustainability benefits for packaging manufacturers. Ongoing tariffs and competitive activity impact sales volumes and pricing in certain segments.
• Creditors: The debt to capital ratio increased to 70%, indicating higher leverage. The company remains in compliance with all debt covenants.
• Suppliers: Purchase obligations primarily consist of commitments for natural gas, electricity, and wood chips.

Next Steps

• USDOC preliminary determinations on HPDP trade petitions expected in the first half of 2026.
• Final investment decisions on eSAF and ethanol-to-jet projects expected in 2025 and early 2026.
• Completion of long-term repair work for the Jesup plant fire expected in early 2027.
• Cash impact associated with Augusta, Georgia, environmental remediation expected in early 2027.
• AGE project expected to come online in late 2028.
• Cash expenditures for Port Angeles, Washington, environmental remediation expected to commence not before 2028.
• Achieve approximately $30 million in annual savings by 2026 from efficiency gains and structural cost reductions.
• Evaluate incremental cost saving opportunities for up to $20 million of additional annual savings in 2027.
• Biomaterials projects expected to add approximately $31 million of run-rate proportional EBITDA exiting 2027.
• Continue to engage opportunistically with interested parties regarding the potential sale of Paperboard and High-Yield Pulp businesses.

Key Dates

Recommendation

The company's Q3 operating performance showed notable improvement, and management has outlined an ambitious long-term strategy for EBITDA growth and cost reductions, particularly in the Biomaterials segment. However, the nine-month results were severely impacted by a significant non-cash DTA write-off, and cash flow remains negative. Persistent market headwinds in Paperboard and High-Yield Pulp, coupled with increasing environmental liabilities and project delays, introduce considerable uncertainty. The high debt-to-capital ratio also warrants caution. While the strategic direction is positive, current financial performance and market challenges suggest a 'hold' position until there is clearer evidence of sustained operational improvement and successful execution of the growth strategy.

Keywords

Cellulose Specialties, Biomaterials, Paperboard, High-Yield Pulp, SEC filing, 10-Q, financial results, EBITDA, cash flow, environmental liabilities, tariffs, sustainable aviation fuel, prebiotics, green energy, debt, Rayonier Advanced Materials